In Vivo Imaging of Cerebral Dopamine D3 Receptors in Alcoholism
David Erritzøe(Imperial College London), Anne Lingford‐Hughes(Hammersmith Hospital), Andri C. Tziortzi(GlaxoSmithKline (United Kingdom)), David Nutt(Imperial College London), Emilio Merlo‐Pich(Roche (Switzerland)), Adam Waldman(Royal Society of Edinburgh), Roger N. Gunn(Mitsubishi Corporation (United Kingdom)), Alessandro Colasanti(Imperial College London), David Bargiela(University of Cambridge), Massimo Bani(GlaxoSmithKline (Italy)), Eugenii A. Rabiner(GlaxoSmithKline (United Kingdom)), John D. Beaver(Biogen (United States)), Graham E. Searle(Unknown)
Cited by 58
Related Papers
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
|Psychopharmacology|2017|969
Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels
|Journal of Neuroscience|1996|879
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
The dopamine theory of addiction: 40 years of highs and lows
|Nature reviews. Neuroscience|2015|653